Medicare’s Drug Price Controls Could Actually Raise Prices In The Long Run

Medicare’s Drug Price Controls Could Actually Raise Prices In The Long Run
Lawmakers promised that letting Medicare set drug prices would save taxpayers more than $100 billion over a decade. New research suggests the IRA may accomplish the opposite in the long run.